16-23478404-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015044.4(GGA2):c.1256T>A(p.Leu419Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000373 in 1,610,276 control chromosomes in the GnomAD database, with no homozygous occurrence. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000034 ( 0 hom. )
Consequence
GGA2
NM_015044.4 missense
NM_015044.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.84
Genes affected
GGA2 (HGNC:16064): (golgi associated, gamma adaptin ear containing, ARF binding protein 2) This gene encodes a member of the Golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) family. This family includes ubiquitous coat proteins that regulate the trafficking of proteins between the trans-Golgi network and the lysosome. These proteins share an amino-terminal VHS domain which mediates sorting of the mannose 6-phosphate receptors at the trans-Golgi network. They also contain a carboxy-terminal region with homology to the ear domain of gamma-adaptins. This family member may play a significant role in cargo molecules regulation and clathrin-coated vesicle assembly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GGA2 | NM_015044.4 | c.1256T>A | p.Leu419Gln | missense_variant | 13/17 | ENST00000309859.8 | NP_055859.1 | |
GGA2 | XM_047433801.1 | c.1226T>A | p.Leu409Gln | missense_variant | 14/18 | XP_047289757.1 | ||
GGA2 | XM_047433802.1 | c.1145T>A | p.Leu382Gln | missense_variant | 13/17 | XP_047289758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GGA2 | ENST00000309859.8 | c.1256T>A | p.Leu419Gln | missense_variant | 13/17 | 1 | NM_015044.4 | ENSP00000311962.4 | ||
GGA2 | ENST00000567468.5 | c.624+8342T>A | intron_variant | 2 | ENSP00000454455.1 | |||||
GGA2 | ENST00000569182.1 | n.442T>A | non_coding_transcript_exon_variant | 4/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249450Hom.: 0 AF XY: 0.0000891 AC XY: 12AN XY: 134754
GnomAD3 exomes
AF:
AC:
25
AN:
249450
Hom.:
AF XY:
AC XY:
12
AN XY:
134754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1458114Hom.: 0 Cov.: 33 AF XY: 0.0000373 AC XY: 27AN XY: 724826
GnomAD4 exome
AF:
AC:
50
AN:
1458114
Hom.:
Cov.:
33
AF XY:
AC XY:
27
AN XY:
724826
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74330
GnomAD4 genome
AF:
AC:
10
AN:
152162
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.1256T>A (p.L419Q) alteration is located in exon 13 (coding exon 13) of the GGA2 gene. This alteration results from a T to A substitution at nucleotide position 1256, causing the leucine (L) at amino acid position 419 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Uncertain
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at